Chemotherapy Market Analysis Report: By Drugs (Alkylating Agents, Antimetabolites, Cytotoxic Agents, Plant Derivatives), By Indication(Lung, Breast, Colorectal, Leukemia), By Drug Delivery Mode(Oral, Intravenous), By End User, By Region (2017-2025)

Global Chemotherapy Market Outlook 2017-2025

Chemotherapy is method for curing cancer that uses anti-cancer agent. Cell division is the foremost action of cancer cells which is made to stop by chemotherapy. Drug delivery in chemotherapy is either site specific or through the bloodstream. Despite the technological advancement in cure of cancer, nearly 8 million people die every year due to cancer. Globally in 2012, there were nearly 14.1 million cancer cases with men having most number of cases. Further the lung cancer is most common type, contributing 13% to the new cases diagnosed, followed by breast cancer (only in women) at 2^nd most common cancer type all over the world. Various advancements in the practice of chemotherapy and drugs used are under trial to lower the after effects of the process and also to make it affordable to low income group of people. Sancar Lab at University of North Carolina are studying the circadian clocks influence on the repairing of DNA cells with the use anti-cancer drug cisplatin. Goldstein Research analyst forecast that the global chemotherapy industry is expected to grow at a CAGR of 63% during 2017-2025 period to reach a market size of USD 128.7 billion by 2025.

Global Chemotherapy Market Segmentation

By Drugs

• Alkylating Agents
• Antimetabolites
• Cytotoxic Agents
• Plant Derivatives

By Indication

• Lung Cancer
• Breast Cancer
• Colorectal cancer
• Leukemia
• Others

By Drug Delivery Mode

• Oral
• Intravenous

By End User

• Hospitals
• Research Institutes

By Geography

• North America (U.S. & Canada)  Chemotherapy  Market {Market Share (%), Market Size (USD Billion)}
• Latin America (Brazil, Mexico, Argentina & Rest Of Latin America)  Chemotherapy  Market {Market Share (%), Market Size (USD Billion)}
• Europe (The U.K., Germany, France, Italy, Hungary, Spain, Poland, Sweden & Roe)  Chemotherapy  Market {Market Share (%), Market Size (USD Billion)}
• Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest Of Asia)  Chemotherapy  Market {Market Share (%), Market Size (USD Billion)}
• Middle East & Africa (GCC, South Africa, North Africa, Romea) Chemotherapy  Market {Market Share (%), Market Size (USD Billion)}

Based on geography, North America region accounted for largest revenue share of 47.8% in 2017 of the global Chemotherapy market. North America accounts for most advanced healthcare and diagnostics facilities. The research and development and application of cancer drugs is largest in the region impacting high growth of the market. North America is followed by Europe on the back of increasing number of pharmaceutical companies and rising research and development in field of cancer.

Covered In This Global Chemotherapy Market Report  

The report covers the present ground scenario and the future growth prospects of the Chemotherapy market for 2017-2025 along with the market players’ analysis. We calculated the market size and revenue share on the basis of revenue generated from major players in the Global region.

Global Chemotherapy Market Outlook 2017-2025, has been prepared based on an in-depth market analysis from farm market experts. The report covers the competitive landscape and current position of major players in the Global Chemotherapy market space. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. “Global Chemotherapy Market Report” also recognizes value chain analysis to understand the cost differentiation, pricing models to provide competitive advantage to the existing and new entry players.

Our Global Chemotherapy market report comprises of the following companies as the key players: Sanofi, Novartis, Pfizer Inc., Eli Lilly & Company, ImClone Systems Inc., GlaxoSmithKline, AstraZeneca, Schering-Plough, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceuticals Industries, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Chemo Espana SL, CELGENE CORPORATION, Amgen Inc, Bayer AG, Takeda Pharmaceutical Company Limited, etc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the farm market. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send us the sample request.

Key questions answered in this Global Chemotherapy Market Report

• What is the total market size by 2025 and what would be the expected growth rate of market?
• What is the total revenue per segment and region in 2017-18 and what would be the expected revenue per segment and region over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry level players?
• What are the recent developments and business strategy of the key players?

Reasons to buy this market study

• Facilitate decision-making based on strong historic and forecast data for global Chemotherapy  market
• Develop strategies based on the latest regulatory framework
• Position yourself to gain the maximum advantage of the global Chemotherapy  market’s growth potential
• Identify key partners and business development avenues across the globe
• Respond to your competitors’ business structure, strategy and prospects